Bioelastomeric materials suitable for the protection of burn areas or the protection of wound repair sites from the occurrence of adhesions

Claim 1

A method for substantially preventing wound adhesion which comprises forming a protective layer between a mammalian wound repair site and a second tissue site wherein said protective layer comprises an elastomeric material capable of reversibly contracting and relaxing by inverse temperature transition wherein a change in chemical potential of a molecular species will effect a change in said inverse temperature transition, and wherein said elastomeric material comprises a bioelastomer containing repeating units selected from the group consisting of elastomeric tetrapeptide and pentapeptide repeating units wherein said repeating units comprise amino acid residues selected from the group consisting by hydrophobic amino acid and glycine residues, and wherein said repeating units exist in a conformation having a β-turn.

Claim 2

A method for substantially preventing wound adhesion which comprises forming a protective layer between a mammalian wound repair site and a second tissue site wherein said protective layer comprises an elastomeric material capable of reversibly contracting and relaxing by inverse temperature transition wherein a change in chemical potential of a molecular species will effect a change in said inverse temperature transition, and wherein said elastomeric material comprises a bioelastomer containing repeating units selected from the group consisting of elastomeric tetrapeptide and pentapeptide repeating units wherein said repeating units comprise amino acid residues selected from the group consisting by hydrophobic amino acid and glycine residues, and wherein said repeating units exist in a conformation having a β-turn.

Claim 3

A method for substantially preventing wound adhesion which comprises forming a protective layer between a mammalian wound repair site and a second tissue site where said protective layer comprises an elastomeric material comprising a bioelastomer containing repeating units selected from the group consisting of elastomeric tetrapeptide and pentapeptide repeating unit wherein said repeating units comprise amino acid residues selected form the group consisting of hydrophobic amino acid and glycine residues, and wherein said repeating units exist in a conformation having a β-turn and said repeating units comprise a polypentapeptide unit of the formula: --X.sup.1 --(IPGVG).sub.n --Y.sup.1 -- where I is a peptide-forming residue of L-isoleucine; P is a peptide-forming residue of L-proline; G is a peptide-forming residue of glycine; V is a peptide-forming residue of L-valine; and wherein X 1 is PGVG, GVG, VG, G or a covalent bond; Y 1 is IPGV, IPG, IP, I or a covalent bond; and n is an integer from 1 to 5,000, or n is 0, with the proviso that X 1 and Y 1 together constitute at least one of said pentameric unit.

Claim 4

A method for substantially preventing wound adhesion which comprises forming a protective layer between a mammalian wound repair site and a second tissue site where said protective layer comprises an elastomeric material comprising a bioelastomer containing repeating units selected from the group consisting of elastomeric tetrapeptide and pentapeptide repeating unit wherein said repeating units comprise amino acid residues selected form the group consisting of hydrophobic amino acid and glycine residues, and wherein said repeating units exist in a conformation having a β-turn and said repeating units comprise a polypentapeptide unit of the formula: --X.sup.1 --(IPGVG).sub.n --Y.sup.1 -- where I is a peptide-forming residue of L-isoleucine; P is a peptide-forming residue of L-proline; G is a peptide-forming residue of glycine; V is a peptide-forming residue of L-valine; and wherein X 1 is PGVG, GVG, VG, G or a covalent bond; Y 1 is IPGV, IPG, IP, I or a covalent bond; and n is an integer from 1 to 5,000, or n is 0, with the proviso that X 1 and Y 1 together constitute at least one of said pentameric unit.

Claim 5

A method for substantially preventing wound adhesion which comprises forming a protective layer between a mammalian wound repair site and a second tissue site wherein said protective layer comprises an elastomeric material comprising a bioelastomer containing repeating units selected from the group consisting of elastomeric tetrapeptide and pentapeptide repeating units wherein said repeating units comprises amino acid residues selected from the group consisting of hydrophobic amino acid and glycine residues, and wherein said repeating units exist in a conformation having a β-turn and said repeating units comprise A) a polypentapeptide unit of the formula: --X.sup.1 --(IPGVG).sub.n --Y.sup.1 -- and B) a polypentapeptide unit of the formula: --X.sup.2 --(VPGVG).sub.n --Y.sup.2 -- wherein for the above formula, I is a peptide-forming residue of L-isoleucine; P is a peptide-forming residue of L-proline; G is a peptide-forming residue of glycine; V is a peptide-forming residue of L-valine; and wherein X 1 and X 2 are each PGVG, GVG, VG, G or a covalent bond; Y 1 is IPGV, IPG, IP, I or a covalent bond; Y 2 is VPGV, VPG, VG, G or a covalent bond; and n in both formulas is an integer from 1 to 200, or n is 0, with the proviso that X 1 and Y 1 or X 2 and Y 2 together constitute at least one of said pentameric unit.

Claim 6

A method for substantially preventing wound adhesion which comprises forming a protective layer between a mammalian wound repair site and a second tissue site wherein said protective layer comprises an elastomeric material comprising a bioelastomer containing repeating units selected from the group consisting of elastomeric tetrapeptide and pentapeptide repeating units wherein said repeating units comprises amino acid residues selected from the group consisting of hydrophobic amino acid and glycine residues, and wherein said repeating units exist in a conformation having a β-turn and said repeating units comprise A) a polypentapeptide unit of the formula: --X.sup.1 --(IPGVG).sub.n --Y.sup.1 -- and B) a polypentapeptide unit of the formula: --X.sup.2 --(VPGVG).sub.n --Y.sup.2 -- wherein for the above formula, I is a peptide-forming residue of L-isoleucine; P is a peptide-forming residue of L-proline; G is a peptide-forming residue of glycine; V is a peptide-forming residue of L-valine; and wherein X 1 and X 2 are each PGVG, GVG, VG, G or a covalent bond; Y 1 is IPGV, IPG, IP, I or a covalent bond; Y 2 is VPGV, VPG, VG, G or a covalent bond; and n in both formulas is an integer from 1 to 200, or n is 0, with the proviso that X 1 and Y 1 or X 2 and Y 2 together constitute at least one of said pentameric unit.

Claim 7

A method for substantially preventing wound adhesion which comprises forming a protective layer between a mammalian wound repair site and a second tissue site wherein said protective layer comprises an elastomeric material comprising a bioelastomer containing repeating units selected from the group consisting of elastomeric tetrapeptide and pentapeptide repeating units wherein said repeating units comprise amino acid residues selected from the group consisting of hydrophobic amino acid and glycine residues, and wherein said repeating units exist in a conformation having a β-tun and said repeating units comprise a tetrapeptide of the formula: --X.sup.3 --(VPGG).sub.n --Y.sup.3 -- wherein X 3 is PGG, GG, G or a covalent bond; Y 3 is VPG, VP, V or a covalent bond; and V is a peptide-producing residue of L-valine; P is a peptide-producing residue of L-proline; and G is a peptide-producing residue of glycine; and n is an integer from 1 to 200, or n is 0, with the proviso that X 3 and Y 3 together constitute at least one of said tetrameric unit.

Claim 8

A method for substantially preventing wound adhesion which comprises forming a protective layer between a mammalian wound repair site and a second tissue site wherein said protective layer comprises an elastomeric material comprising a bioelastomer containing repeating units selected from the group consisting of elastomeric tetrapeptide and pentapeptide repeating units wherein said repeating units comprise amino acid residues selected from the group consisting of hydrophobic amino acid and glycine residues, and wherein said repeating units exist in a conformation having a β-tun and said repeating units comprise a tetrapeptide of the formula: --X.sup.3 --(VPGG).sub.n --Y.sup.3 -- wherein X 3 is PGG, GG, G or a covalent bond; Y 3 is VPG, VP, V or a covalent bond; and V is a peptide-producing residue of L-valine; P is a peptide-producing residue of L-proline; and G is a peptide-producing residue of glycine; and n is an integer from 1 to 200, or n is 0, with the proviso that X 3 and Y 3 together constitute at least one of said tetrameric unit.

Claim 9

A method for substantially preventing wound adhesion which comprises forming a protective layer between a mammalian wound repair site and a second tissue site wherein said protective layer comprises and elastomeric material comprising a bioelastomer containing repeating units selected from the group consisting of elastomeric tetrapeptide and pentapeptide repeating units wherein said repeating units comprise amino acid residues selected from the group consisting of hydrophobic amino acid and glycine residues, and wherein said repeating units exist in a conformation having a β-turn and said repeating units comprise a tetrapeptide of the formula: --X.sup.4 --(IPGG).sub.n --Y.sup.4 -- wherein X 4 is PGG, GG, G or a covalent bond; Y 4 is IPG, IP, I or a covalent bond; and I is a peptide-producing residue of L-isoleucine; P is a peptide-producing residue of L-proline; and G is a peptide-producing residue of glycine; and n is an integer from 1 to 200, or n is 0, with the proviso that X 4 and Y 4 together constitute at least one of said tetrameric unit.

Claim 10

A method for substantially preventing wound adhesion which comprises forming a protective layer between a mammalian wound repair site and a second tissue site wherein said protective layer comprises and elastomeric material comprising a bioelastomer containing repeating units selected from the group consisting of elastomeric tetrapeptide and pentapeptide repeating units wherein said repeating units comprise amino acid residues selected from the group consisting of hydrophobic amino acid and glycine residues, and wherein said repeating units exist in a conformation having a β-turn and said repeating units comprise a tetrapeptide of the formula: --X.sup.4 --(IPGG).sub.n --Y.sup.4 -- wherein X 4 is PGG, GG, G or a covalent bond; Y 4 is IPG, IP, I or a covalent bond; and I is a peptide-producing residue of L-isoleucine; P is a peptide-producing residue of L-proline; and G is a peptide-producing residue of glycine; and n is an integer from 1 to 200, or n is 0, with the proviso that X 4 and Y 4 together constitute at least one of said tetrameric unit.

Claim 11

A method for substantially preventing wound adhesion which comprises forming a protective layer between a mammalian wound repair site and a second tissue site wherein said protective layer comprises an elastomeric material comprising a bioelastomer containing repeating units selected from the group consisting of elastomeric tetrapeptide and pentapeptide repeating units wherein said repeating unit comprise amino acid residues selected from the group consisting of hydrophobic amino acid and glycine residues, and wherein said repeating units exist in a conformation having a β-turn and said repeating units comprise a pentapeptide repeating unit of the formula: (R.sub.1 PR.sub.2 R.sub.3 G).sub.n wherein R 1 is a peptide-producing residue selected from the group consisting of Phe, Leu, Ile, and Val; R 2 is such a residue selected from the group consisting of Ala and Gly; R 3 is such a residue selected from the group consisting of Phe, Leu, Ile, and Val; P is a L-proline-producing residue, and G is a glycine-producing residue, and n is an integer from 1 to about 5,000.

Claim 12

A method for substantially preventing wound adhesion which comprises forming a protective layer between a mammalian wound repair site and a second tissue site wherein said protective layer comprises an elastomeric material comprising a bioelastomer containing repeating units selected from the group consisting of elastomeric tetrapeptide and pentapeptide repeating units wherein said repeating unit comprise amino acid residues selected from the group consisting of hydrophobic amino acid and glycine residues, and wherein said repeating units exist in a conformation having a β-turn and said repeating units comprise a pentapeptide repeating unit of the formula: (R.sub.1 PR.sub.2 R.sub.3 G).sub.n wherein R 1 is a peptide-producing residue selected from the group consisting of Phe, Leu, Ile, and Val; R 2 is such a residue selected from the group consisting of Ala and Gly; R 3 is such a residue selected from the group consisting of Phe, Leu, Ile, and Val; P is a L-proline-producing residue, and G is a glycine-producing residue, and n is an integer from 1 to about 5,000.

Claim 13

A method for substantially preventing wound adhesion which comprises forming a protective layer between a mammalian wound repair set and a second tissue site wherein said protective layer comprises an elastomeric material comprising a bioelastomer containing repeating units selected from the group consisting of elastomeric tetrapeptide and pentapeptide repeating units wherein said repeating units comprise amino acid residues selected from the group consisting of hydrophobic amino acid and glycine residues, and wherein said repeating units exits in conformation having a β-turn and said repeating units comprise a tetrapeptide repeating unit of the formula: (R.sub.1 PGG).sub.n wherein R 1 is a peptide-producing residue selected from the group consisting of Phe, Leu, Ile, and Val; P is a L-proline-producing residue, and G is a glycine-producing residue, and n is an integer from 1 to about 5,000.

Claim 14

A method for substantially preventing wound adhesion which comprises forming a protective layer between a mammalian wound repair set and a second tissue site wherein said protective layer comprises an elastomeric material comprising a bioelastomer containing repeating units selected from the group consisting of elastomeric tetrapeptide and pentapeptide repeating units wherein said repeating units comprise amino acid residues selected from the group consisting of hydrophobic amino acid and glycine residues, and wherein said repeating units exits in conformation having a β-turn and said repeating units comprise a tetrapeptide repeating unit of the formula: (R.sub.1 PGG).sub.n wherein R 1 is a peptide-producing residue selected from the group consisting of Phe, Leu, Ile, and Val; P is a L-proline-producing residue, and G is a glycine-producing residue, and n is an integer from 1 to about 5,000.

Claim 15

A method for substantially preventing wound adhesion which comprises forming a protective layer between a mammalian wound repair site and a second tissue site wherein said protective layer comprises an elastomeric material comprising repeating units comprise a polypentapeptide unit of the formula: --X.sup.1 --(VPGVG)--Y.sup.1 -- wherein V is a peptide-forming residue of L-valine; P is a peptide-forming residue of L-proline; G is a peptide-forming residue of glycine; and wherein X 1 is PGVG, GVG, VG or G or a covalent bond; Y 1 is VPGV, VPG, VP or V or a covalent bond; and n is an integer from 1 to about 5,000, or n is 0, with the proviso that X 1 and Y 1 together constitute at least one of said pentameric unit.

Claim 16

A method for substantially preventing wound adhesion which comprises forming a protective layer between a mammalian wound repair site and a second tissue site wherein said protective layer comprises an elastomeric material comprising repeating units comprise a polypentapeptide unit of the formula: --X.sup.1 --(VPGVG)--Y.sup.1 -- wherein V is a peptide-forming residue of L-valine; P is a peptide-forming residue of L-proline; G is a peptide-forming residue of glycine; and wherein X 1 is PGVG, GVG, VG or G or a covalent bond; Y 1 is VPGV, VPG, VP or V or a covalent bond; and n is an integer from 1 to about 5,000, or n is 0, with the proviso that X 1 and Y 1 together constitute at least one of said pentameric unit.

Claim 17

The method of any one of claims 1-8, wherein said elastomeric material is in the form of a strip, ribbon or sheet.

Claim 18

The method of any one of claims 1-8, wherein said elastomeric material is in the form of a powder, gel or foam.

Claim 19

The method of any one of claim s 1-8, wherein said elastomeric material is substantially cross-linked.

Claim 20

The method of any one of claims 1-8, wherein said elastomeric material is substantially uncrosslinked.

Claim 21

The method of any one of claim s 1-8, wherein said bioelastomer additionally comprise hexapeptide repeating units of the formula: --X(APGVGV).sub.n --Y-- wherein A is a peptide-forming residue of L-alanine; P is a peptide-forming residue of L-proline; G is a peptide-forming residue of glycine; V is a peptide-forming residue of L-valine; and X is PGVGV, GVGV, VGV, GV, V or a covalent bond; Y is APGVG, APGV, APG, AP, A or a covalent bond; and n is an integer of from 2 to about 5,000, wherein this hexameric segment contains at least 18 amino acid residues.

Claim 22

The method of any one of claims 1-8, wherein said method steps comprise: preparing said elastomeric material comprising a bioelastomer containing repeating units selected from the group consisting of elastomeric tetrapeptide and pentapeptide repeating units and combinations thereof, and applying an effective amount of said elastomeric material to said mammalian wound repair site, wherein said elastomeric material forms a barrier to isolate said mammalian wound repair site such that connective tissue will not form between said mammalian wound repair site and said second tissue site.

Claim 24

The method of any one of claims 1-8, where said mammalian wound repair site is an incision or a burn.

Claim 25

The method of any one of claims 1-8, wherein said elastomeric material is biodegradable.

Claim 26

The method of any one of claims 1-8, wherein said elastomeric material is readily steilizable.

Claim 27

The method of any one of claims 1-8, wherein said elastomeric material elicits insignificant immunogenic or antigenic responses.